9.23
price down icon0.97%   -0.09
after-market Dopo l'orario di chiusura: 9.33 0.10 +1.08%
loading
Precedente Chiudi:
$9.32
Aprire:
$9.45
Volume 24 ore:
1.23M
Relative Volume:
0.96
Capitalizzazione di mercato:
$492.43M
Reddito:
$1.02B
Utile/perdita netta:
$-757.20M
Rapporto P/E:
-0.6253
EPS:
-14.76
Flusso di cassa netto:
$-257.90M
1 W Prestazione:
+4.41%
1M Prestazione:
+28.91%
6M Prestazione:
+19.71%
1 anno Prestazione:
-2.84%
Intervallo 1D:
Value
$9.225
$9.66
Intervallo di 1 settimana:
Value
$8.80
$9.66
Portata 52W:
Value
$4.02
$12.73

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
Nome
Emergent Biosolutions Inc
Name
Telefono
240-631-3200
Name
Indirizzo
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
Dipendente
900
Name
Cinguettio
@emergentbiosolu
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
EBS's Discussions on Twitter

Confronta EBS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
9.23 483.89M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.62 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.52 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.82 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.46 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.23 14.21B 2.99B 1.21B 1.13B 25.06

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-30 Iniziato H.C. Wainwright Buy
2024-08-22 Iniziato Rodman & Renshaw Buy
2024-03-07 Aggiornamento The Benchmark Company Hold → Buy
2023-11-20 Ripresa JP Morgan Underweight
2023-08-29 Downgrade The Benchmark Company Buy → Hold
2023-04-10 Aggiornamento The Benchmark Company Hold → Buy
2023-03-17 Downgrade JP Morgan Neutral → Underweight
2022-11-10 Downgrade The Benchmark Company Buy → Hold
2022-04-29 Downgrade Cantor Fitzgerald Overweight → Neutral
2022-01-20 Aggiornamento The Benchmark Company Hold → Buy
2021-11-08 Downgrade The Benchmark Company Buy → Hold
2021-05-05 Downgrade Argus Buy → Hold
2021-04-07 Iniziato The Benchmark Company Buy
2021-02-24 Aggiornamento Chardan Capital Markets Neutral → Buy
2021-02-19 Downgrade Chardan Capital Markets Buy → Neutral
2021-01-08 Downgrade Wells Fargo Overweight → Equal Weight
2020-09-14 Ripresa JP Morgan Neutral
2020-07-31 Reiterato Chardan Capital Markets Buy
2019-09-12 Iniziato Guggenheim Buy
2019-09-04 Aggiornamento Wells Fargo Market Perform → Outperform
2018-11-02 Aggiornamento Goldman Neutral → Buy
2018-08-03 Reiterato Chardan Capital Markets Buy
2018-06-13 Iniziato Argus Buy
2018-04-25 Downgrade Wells Fargo Outperform → Market Perform
2018-01-24 Iniziato Goldman Neutral
2018-01-16 Reiterato Chardan Capital Markets Buy
2016-06-28 Reiterato Singular Research Buy
2016-04-15 Iniziato Chardan Capital Markets Buy
2016-03-28 Iniziato Singular Research Buy
2016-02-19 Iniziato Wells Fargo Outperform
2014-05-15 Iniziato Summer Street Research Buy
2011-05-31 Reiterato WBB Securities Strong Buy
2011-01-10 Reiterato Wedbush Outperform
2010-11-05 Reiterato Wedbush Outperform
2010-08-18 Aggiornamento WBB Securities Buy → Strong Buy
2010-08-06 Reiterato Caris & Company Buy
Mostra tutto

Emergent Biosolutions Inc Borsa (EBS) Ultime notizie

pulisher
Aug 20, 2025

Analysts Apply Wyckoff Model to Emergent BioSolutions Inc. Stock2025 Market WrapUp & Fast Moving Market Watchlists - beatles.ru

Aug 20, 2025
pulisher
Aug 20, 2025

Technical Bounce Expected in Emergent BioSolutions Inc. Next WeekJuly 2025 Analyst Calls & Risk Managed Trade Strategies - thegnnews.com

Aug 20, 2025
pulisher
Aug 19, 2025

Emergent BioSolutions : From Cost Center to Value Driver - MarketScreener

Aug 19, 2025
pulisher
Aug 19, 2025

Three Analyst Favorites with Potential for Further Gains: SkyWater Technology, Emergent BioSolutions, and More - AInvest

Aug 19, 2025
pulisher
Aug 16, 2025

Is Emergent BioSolutions Inc. stock forming a cup and handleTrade Volume Summary & High Conviction Buy Zone Picks - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Emergent BioSolutions Board Member Sells $67K in Company Stock Amid Revenue Decline. - AInvest

Aug 16, 2025
pulisher
Aug 16, 2025

Emergent BioSolutions signs contract modification award for CNJ-016 - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact Its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEO’s Insider Sales - ACCESS Newswire

Aug 15, 2025
pulisher
Aug 15, 2025

Emergent BioSolutions' (NYSE:EBS) Solid Earnings May Rest On Weak Foundations - simplywall.st

Aug 15, 2025
pulisher
Aug 15, 2025

Emergent BioSolutions Inc. (NYSE:EBS) Held Back By Insufficient Growth Even After Shares Climb 27% - 富途牛牛

Aug 15, 2025
pulisher
Aug 15, 2025

We Think That There Are Some Issues For Emergent BioSolutions (NYSE:EBS) Beyond Its Promising Earnings - Yahoo Finance

Aug 15, 2025
pulisher
Aug 14, 2025

Emergent BioSolutions Inc. Outperforms Peers on Volume MetricsQuarterly Risk Review & Smart Allocation Stock Reports - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

RSI Suggests Rebound May Be Near in Emergent BioSolutions Inc.2025 Volume Leaders & Daily Stock Momentum Reports - beatles.ru

Aug 14, 2025
pulisher
Aug 13, 2025

Emergent BioSolutions Director Sells 7,844 Shares at $8.65/Share on August 12, 2025. - AInvest

Aug 13, 2025
pulisher
Aug 12, 2025

Emergent BioSolutions’ Earnings Call Highlights Strong Financial Performance - The Globe and Mail

Aug 12, 2025
pulisher
Aug 12, 2025

Emergent BioSolutions’ Strong Q2 Fuels Hopes for 2025 Rally - citybiz

Aug 12, 2025
pulisher
Aug 12, 2025

300 new jobs headed to Bayview manufacturing plant - The Business Journals

Aug 12, 2025
pulisher
Aug 12, 2025

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally - Seeking Alpha

Aug 12, 2025
pulisher
Aug 11, 2025

Emergent Biosolutions: Strategic Advancements and Financial Performance Drive Buy Rating - TipRanks

Aug 11, 2025
pulisher
Aug 10, 2025

Emergent BioSolutions Reports Improved Q2 2025 Results - TipRanks

Aug 10, 2025
pulisher
Aug 10, 2025

Published on: 2025-08-10 18:27:00 - metal.it

Aug 10, 2025
pulisher
Aug 10, 2025

Earnings Update: Here's Why Analysts Just Lifted Their Emergent BioSolutions Inc. (NYSE:EBS) Price Target To US$13.50 - simplywall.st

Aug 10, 2025
pulisher
Aug 09, 2025

Emergent BioSolutions Inc. (NYSE:EBS) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 09, 2025
pulisher
Aug 09, 2025

Emergent Biosolutions (EBS) Q1 Earnings Top Estimates - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Emergent BioSolutions' Strong ROE Amid Industry Average: A Financial Analysis - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Can Emergent BioSolutions Inc. (NYSE:EBS) Maintain Its Strong Returns? - Yahoo Finance

Aug 09, 2025
pulisher
Aug 08, 2025

Emergent BioSolutions to participate in investor conferences in May and June 2025. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛

Aug 08, 2025
pulisher
Aug 08, 2025

Emergent BioSolutions Updates FY25 Revenue Guidance to $765M-$835M - AInvest

Aug 08, 2025
pulisher
Aug 07, 2025

BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd - Law360

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent BioSolutions Surpasses Q2 Revenue Expectations - The Globe and Mail

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent BioSolutions reports Q2 adjusted EPS 16c vs ($2.32) last year - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent BioSolutions Soars 22% on Earnings Surprise: What's Fueling the Surge? - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent Biosolutions reports second quarter loss - Maryland Daily Record

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent Biosolutions shares rise 6.14% premarket after securing $51.9 million contract modification for smallpox preparedness. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Installed Building Products reports record Q2 2025 results, 3.1% revenue increase. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent Biosolutions Q2 Earnings Report: $12 Million LossNews and Statistics - IndexBox

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent Biosolutions: Q2 Earnings Snapshot - Huron Daily Tribune

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent BioSolutions Inc. SEC 10-Q Report - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings call transcript: Emergent BioSolutions Q2 2025 results show mixed performance - Investing.com

Aug 07, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Outpaces Its Own Forecasts But Misses Analyst Targets - Finimize

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent Biosolutions earnings beat by $0.26, revenue fell short of estimates - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Q2 revenue misses analyst expectations - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Inc Q2 2025 Earnings: EPS of -$0.22 Beats Estimates, Revenue Surges to $140.9 Million - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Q2 2025 slides: Profitability improves as transformation continues - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent Biosolutions Q2 Earnings: Non-GAAP EPS Beats by $0.65, Revenue Misses by $5.47M - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Reports Second Quarter 2025 Financial Results - The Manila Times

Aug 06, 2025
pulisher
Aug 04, 2025

Emergent BioSolutions Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView

Aug 04, 2025
pulisher
Aug 03, 2025

What drives Emergent BioSolutions Inc. stock priceInvest confidently with real-time data analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Emergent BioSolutions Inc. stockMaximize your portfolio’s growth potential - Jammu Links News

Aug 03, 2025

Emergent Biosolutions Inc Azioni (EBS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$29.75
price up icon 2.37%
$17.91
price up icon 2.40%
drug_manufacturers_specialty_generic RDY
$14.51
price up icon 0.62%
$10.65
price down icon 0.37%
$135.43
price up icon 0.11%
$312.23
price up icon 0.51%
Capitalizzazione:     |  Volume (24 ore):